| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 170 |
| 1 | ETANERCEPT | 164 |
| 2 | RITUXIMAB | 158 |
| 3 | LEFLUNOMIDE | 157 |
| 4 | METHOTREXATE | 157 |
| 5 | ADALIMUMAB | 156 |
| 6 | SULFASALAZINE | 152 |
| 7 | TOCILIZUMAB | 152 |
| 8 | TOFACITINIB | 150 |
| 9 | HYDROXYCHLOROQUINE SULFATE | 148 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE PROBUTATE | 19 | 0.2468 |
| 1 | CETRIMIDE | 21 | 0.1544 |
| 2 | 200 WET WIPES | 46 | 0.0720 |
| 3 | TETRAHYDROZOLINE HYDROCHLORIDE | 4 | 0.0513 |
| 4 | HYDROCORTISONE BUTYRATE | 56 | 0.0278 |
| 5 | HYALURONIDASE (HUMAN RECOMBINANT) | 8 | 0.0265 |
| 6 | DICLOFENAC POTASSIUM TABLETS | 87 | 0.0253 |
| 7 | CAFFEINE CITRATE | 31 | 0.0242 |
| 8 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 8 | 0.0240 |
| 9 | PSEUDOEPHEDRINE HYDROCHLORIDE | 105 | 0.0190 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 172 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 169 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 159 |
| 3 | Corticosteroid [EPC] | 159 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 158 |
| 5 | Antirheumatic Agent [EPC] | 157 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 157 |
| 7 | Aminosalicylate [EPC] | 152 |
| 8 | Vitamin C [EPC] | 143 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 142 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 22 | 0.0073 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 34 | 0.0021 |
| 2 | Histamine-1 Receptor Antagonist [EPC] | 78 | 0.0020 |
| 3 | Antirheumatic Agent [EPC] | 157 | 0.0018 |
| 4 | Tetracycline-class Drug [EPC] | 89 | 0.0017 |
| 5 | Methylxanthine [EPC] | 71 | 0.0017 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 158 | 0.0016 |
| 7 | Interleukin-12 Antagonist [EPC] | 125 | 0.0016 |
| 8 | Aminosalicylate [EPC] | 152 | 0.0014 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 142 | 0.0013 |